Pulmonary Disease Doctors in Glendale, AZ Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Jessica Zeman, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6677 W Thunderbird Rd, Bldg E, Glendale, AZ 85306 Phone: 623-815-7800

Samer Makhoul, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 480-985-1093    Fax: 480-296-7665

Carla Jean Rotering, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6677 W Thunderbird Rd Bldg E, Glendale, AZ 85306 Phone: 623-776-1411    Fax: 623-776-1171

Dr. Jeffrey Alan Grill, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5757 W Thunderbird Rd Ste W202, Glendale, AZ 85306 Phone: 602-298-1932    Fax: 602-862-1131

Manjit Bhamrah, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13606 N 59th Ave, Suite 1, Glendale, AZ 85304 Phone: 602-978-6100

Dr. Salam Rafique, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 602-978-6100    Fax: 602-978-2446

Miquel Dean Gomez Ii, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10150 N 67th Ave Ste 101, Glendale, AZ 85302 Phone: 623-561-4547    Fax: 623-412-4995

News Archive

New study identifies challenges in end-of-life care

Most nurses that work in a children's critical care unit feel prepared and trained to help parents during the final moments of their child's life and the difficult hours that follow.

Study could lead towards a personalised medicine for chemoresistant lymphomata

To date, tests have only been carried out on cells, but a piece of research conducted by the Department of Genetics at the UPV/EHU's Faculty of Medicine in collaboration with MD Anderson and the CNIO is opening up the door for the treatment of lymphoma types that have a lower survival rate. The study of the molecular characteristics of the tumours would enable molecules that are altered in a specific way to be identified and turned into new therapeutic targets that would improve the prognosis of patients with chemoresistant lymphomata.

New drug treatment could soon benefit people with rheumatoid arthritis

People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.

Experts discuss latest advancements in gynecological diseases at 2nd China Research Forum

DK Sinopharma, Inc. successfully co-hosted the 2nd China Western Gynecological Diseases Research Forum along with China Physician Association Gynecology Branch and Shaanxi Pharmacology Academic Council. Many experts and scholars in gynecology attended the conference, including 146 gynecologists from large hospitals across China.

Read more Medical News

› Verified 6 days ago